Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Publication Type:

Journal Article


The Journal of urology, Volume 181, Issue 3, p.956-62 (2009)


2009, Aged, Center-Authored Paper, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, PROSTATECTOMY, Prostatic Neoplasms, Public Health Sciences Division, Radiotherapy, Adjuvant, Risk Factors, Survival Rate, Time Factors


Extraprostatic disease will be manifest in a third of men after radical prostatectomy. We present the long-term followup of a randomized clinical trial of radiotherapy to reduce the risk of subsequent metastatic disease and death.